Please login to the form below

Not currently logged in
Email:
Password:

Bray Leino opens health and wellbeing PR practice

Appoints Hayley Knight to run Rx, OTC and wellbeing services
Bray Leino, Hayley Knight

UK communications group Bray Leino has launched a health and wellbeing offering as part of its PR business.

The practice will focus on promoting Rx, OTC and wellbeing brands, along with health awareness charities and campaigns, and will be lead by newly appointed healthcare consultant Hayley Knight (pictured).

Based in Bristol and reporting to head of health and wellbeing Sally Bradford, Knight has 17-years of PR experience, having previously worked for Ketchum, Just Health PR, Red Door Communications, Cohn & Wolfe and Munro & Forster.

She has worked on campaigns for ADHD brands and public affairs for Shire Pharmaceuticals: cardiology products for AstraZeneca, Sanofi and Eli Lilly; mental health for Wyeth; diagnostics and devices for Roche Diagnostics; and chronic pain for Pfizer.

"We hit a critical mass of health and wellbeing clients within the PR business which made it apt for us to set up a specialist practice so we could be single minded in our delivery and offer,” Bradford said.

“It's serendipitous that we've been able to hire Hayley, who has outstanding experience and a formidable reputation within the healthcare industry.”

Commenting on her appointment, Knight said: “Our remit is to meet and dissect the challenges faced by clients as the NHS gears-up for the greatest shift in power in recent decades.

“Bray Leino has impressive heritage with the health consumer and the group has a truly integrated offering - I am delighted to join the health and wellbeing team at such a time."

3rd December 2012

From: Marketing, Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Star

We're passionate about helping our clients to make a real commercial impact. We achieve this through our unique approach to...

Latest intelligence

China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...

Infographics